Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Salicylic acid, Lactic acid may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
SALACTOL
Flat size: 144mm x 340mm
D. Unscrew the cap of the bottle and, using the applicator attached to the inside of the cap, carefully apply a few drops of the paint to the top of the wart, verruca, corn or callus only:
4. POSSIBLE SIDE EFFECTS
Like all medicines, Salactol can cause side effects although not everybody gets them:
not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
5. HOW TO STORE SALACTOL
Salactol 6. Contents of the pack and other information
1. WHAT SALACTOL IS AND WHAT IT IS USED FOR •
• • •
Salactol is a collodion wart paint for treating warts, verrucas, corns and calluses.
2. WHAT YOU NEED TO KNOW BEFORE YOU USE SALACTOL
Do not use Salactol if you are allergic (hypersensitive) to salicylic acid, lactic acid or any of the other ingredients of Salactol listed in Section 6.
Prints: Pantone 469
PP5/25/2 202872
What Salactol contains: The active ingredients are salicylic acid (16.7% w/w) and lactic acid (16.7% w/w). The other ingredients are pyroxylin (contains isopropyl alcohol as a damping solvent), colophony, castor oil, industrial methylated spirit and ether. What Salactol looks like and contents of the pack This amber glass bottle contains 10 ml of collodion wart paint. The paint is colourless or pale yellow/brown. The bottle cap incorporates a specially designed applicator spatula.
To listen to or request a copy of this leaflet in Braille, large print or audio, please call free of charge: 0800 198 5000 (UK only). Please be ready to give the following information: Salactol, 00173/5006 This is a service provided by the Royal National Institute of Blind People (RNIB).
Prints: Pantone 469
PP5/25/2 202872
Marketing Authorisation holder Dermal Laboratories, Hitchin, Herts, SG4 7QR. Manufacturer Aeropak, Viking Road, Great Yarmouth, Norfolk, NR31 0NU, UK. This leaflet was last revised in July 2025.
Flat size: 144mm x 340mm
The active substance in Salactol Collodion is salicylic acid, lactic acid.
Medicines with the same active substance, strength and form include: Duofilm. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Salactol Collodion, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
For the topical treatment of warts, verrucas, corns and calluses.
For adults, children and the elderly.
Salactol should be applied once daily usually at night. It can take up to twelve (12) weeks for resistant lesions to disappear, and it is necessary to persevere with the treatment.
Soak the affected site in warm water and pat dry. Gently rub the surface of the wart, verruca, corn or callus with a pumice stone or manicure emery board to remove any hard skin. Using the applicator provided, carefully apply a few drops of Salactol to the lesion, allowing each drop to dry before applying the next one. Take care to localise the application to the affected area. Plantar warts should be covered with an adhesive plaster. Leave for 24 hours. Repeat the procedure daily, after first removing any plaster.
Not to be used on or near the face, intertriginous or anogenital regions or by diabetics or individuals with impaired peripheral blood circulation.
Not to be used on moles, birthmarks, hairy warts or on any other skin lesions for which Salactol is not indicated.
Not to be used in cases of sensitivity to any of the ingredients.
Keep away from the eyes and mucous membranes.
The gel should be applied carefully to the wart, verruca, corn or callus only to avoid possible irritation of surrounding normal skin.
Some mild, transient irritation may be expected, but in cases of more severe or persistent pain/irritation, the treatment should be suspended and/or discontinued. See also Section 4.8.
Extremely flammable.
Avoid spillage.
Avoid inhaling vapour.
Replace cap tightly alter use.
None known
There are no or limited amount of data from the use of Salactol Collodion during pregnancy.
Salactol Collodion should not be used during pregnancy, except for short-term treatment of a small single wart, verruca, corn or callus.
It is not known if the systemic Salactol Collodion exposure reached after topical administration can be harmful to an embryo/fetus.
During the third trimester of pregnancy, systemic use of prostaglandin synthetase inhibitors may induce cardiopulmonary and renal toxicity in the fetus. At the end of the pregnancy prolonged bleeding time in both mother and child may occur, and labour can be delayed.
None known.
Salactol may be irritant in certain patients, which in rare instances may appear as a temporary blemish on the skin. See also Section 4.4.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Any excessive use of Salactol could cause irritation of the skin. If this occurs, Salactol should be used more sparingly or applied less frequently.
Accidental oral ingestion should be treated immediately by gastric lavage with a 2 to 5% aqueous sodium bicarbonate solution. Fluid and electrolyte balance should be monitored and appropriate supportive measures should be provided. Symptoms include headache, nausea, vomiting, diarrhoea and respiratoty depression.
Ask anything about Salactol Collodion. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.